Literature DB >> 16733674

Magnetization transfer ratio and volumetric analysis of the brain in macrocephalic patients with neurofibromatosis type 1.

Persefoni N Margariti1, Konstantinos Blekas, Frosso G Katzioti, Anastasia K Zikou, Meropi Tzoufi, Maria I Argyropoulou.   

Abstract

The purpose of the study was to evaluate brain myelination by measuring the magnetization transfer ratio (MTR) and to measure grey (GMV) and white matter volume (WMV) in macrocephalic children with neurofibromatosis type 1 (NF1). Seven NF1 patients (aged 0.65-16.67 years) and seven age- and gender-matched controls were studied. A three-dimensional (3D) gradient echo sequence with and without magnetization transfer (MT) prepulse was used for MTR assessment. Volume measurements of GM and WM were performed by applying segmentation techniques on T2-weighted turbo spin echo images (T2WI). MTR of unidentified bright objects (UBOs) on T2WI in cerebellar white matter (52.8+/-3.3), cerebral peduncles (48.5+/-1.5), hippocampus (52.6+/-1.1), internal capsule (55.7+/-0.3), globus pallidus (52.7+/-3.9), and periventricular white matter (52.6+/-1.2) was lower than in the corresponding areas of controls (64.6+/-2.5, 60.8+/-1.3, 56.4+/-0.9, 64.7+/-1.9, 59.2+/-2.3, 63.6+/-1.7, respectively; p<0.05). MTR of normal-appearing brain tissue in patients was not significantly different than in controls. Surface area (mm(2)) of the corpus callosum (809.1+/-62.8), GMV (cm(3)) (850.7+/-42.9), and white matter volume (WMV) (cm(3)) (785.1+/-85.2) were greater in patients than in controls (652.5+/-52.6 mm(2), 611.2+/-92.1 cm(3), 622.5+/-108.7 cm(3), respectively; p<0.05). To conclude, macrocephaly in NF1 patients is related to increased GMV and WMV and corpus callosum enlargement. MTR of UBOs is lower than that of normal brain tissue.

Entities:  

Mesh:

Year:  2006        PMID: 16733674     DOI: 10.1007/s00330-006-0323-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  32 in total

1.  Characterizing white matter with magnetization transfer and T(2).

Authors:  G J Stanisz; A Kecojevic; M J Bronskill; R M Henkelman
Journal:  Magn Reson Med       Date:  1999-12       Impact factor: 4.668

2.  MR imaging of the corpus callosum in pediatric patients with neurofibromatosis type 1.

Authors:  E C Dubovsky; T N Booth; G Vezina; C A Samango-Sprouse; K M Palmer; C O Brasseux
Journal:  AJNR Am J Neuroradiol       Date:  2001-01       Impact factor: 3.825

Review 3.  Concepts of myelin and myelination in neuroradiology.

Authors:  A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

4.  Neurofibromin, the neurofibromatosis type 1 Ras-GAP, is required for appropriate P0 expression and myelination.

Authors:  T Rosenbaum; H A Kim; Y L Boissy; B Ling; N Ratner
Journal:  Ann N Y Acad Sci       Date:  1999-09-14       Impact factor: 5.691

Review 5.  Magnetization transfer imaging to monitor clinical trials in multiple sclerosis.

Authors:  N D Richert; J A Frank
Journal:  Neurology       Date:  1999       Impact factor: 9.910

6.  Diffusion MRI in neurofibromatosis type 1: ADC evaluations of the optic pathways, and a comparison with normal individuals.

Authors:  R N Sener
Journal:  Comput Med Imaging Graph       Date:  2002 Mar-Apr       Impact factor: 4.790

7.  Magnetization transfer ratio measurements of the brain in children with tuberous sclerosis complex.

Authors:  Anastasia Zikou; Maria-Christina Ioannidou; Meropi Tzoufi; Loukas Astrakas; Maria I Argyropoulou
Journal:  Pediatr Radiol       Date:  2005-07-29

8.  Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities.

Authors:  R G Steen; J S Taylor; J W Langston; J O Glass; V R Brewer; W E Reddick; R Mages; E K Pivnick
Journal:  AJNR Am J Neuroradiol       Date:  2001-05       Impact factor: 3.825

9.  Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain.

Authors:  D P DiPaolo; R A Zimmerman; L B Rorke; E H Zackai; L T Bilaniuk; A T Yachnis
Journal:  Radiology       Date:  1995-06       Impact factor: 11.105

10.  A comparison between magnetization transfer ratios and myelin water percentages in normals and multiple sclerosis patients.

Authors:  I M Vavasour; K P Whittall; A L MacKay; D K Li; G Vorobeychik; D W Paty
Journal:  Magn Reson Med       Date:  1998-11       Impact factor: 4.668

View more
  17 in total

Review 1.  Neural phenotypes of common and rare genetic variants.

Authors:  Carrie E Bearden; David C Glahn; Agatha D Lee; Ming-Chang Chiang; Theo G M van Erp; Tyrone D Cannon; Allan L Reiss; Arthur W Toga; Paul M Thompson
Journal:  Biol Psychol       Date:  2008-02-23       Impact factor: 3.251

2.  Fetal thick corpus callosum: new insights from neuroimaging and neuropathology in two cases and literature review.

Authors:  Giana Izzo; Valentina Toto; Chiara Doneda; Cecilia Parazzini; Mariano Lanna; Gaetano Bulfamante; Andrea Righini
Journal:  Neuroradiology       Date:  2021-05-21       Impact factor: 2.804

3.  PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.

Authors:  Emily M Johnson; Alexandra D Ishak; Paige E Naylor; David A Stevenson; Allan L Reiss; Tamar Green
Journal:  Cereb Cortex       Date:  2019-07-05       Impact factor: 5.357

4.  Magnetization transfer imaging of normal and abnormal testis: preliminary results.

Authors:  Athina C Tsili; Alexandra Ntorkou; Dimitrios Baltogiannis; Anastasios Sylakos; Sotirios Stavrou; Loukas G Astrakas; Vasilios Maliakas; Nikolaos Sofikitis; Maria I Argyropoulou
Journal:  Eur Radiol       Date:  2015-06-12       Impact factor: 5.315

5.  Non-arteritic anterior ischaemic optic neuropathy: evaluation of the brain and optic pathway by conventional MRI and magnetisation transfer imaging.

Authors:  Maria I Argyropoulou; Anastasia K Zikou; Ioanna Tzovara; Alexios Nikas; Kostandinos Blekas; Persefoni Margariti; Nikolaos Galatsanos; Ioannis Asproudis
Journal:  Eur Radiol       Date:  2006-11-28       Impact factor: 5.315

6.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598

7.  Bilateral posterior periventricular nodular heterotopia: a recognizable cortical malformation with a spectrum of associated brain abnormalities.

Authors:  S A Mandelstam; R J Leventer; A Sandow; G McGillivray; M van Kogelenberg; R Guerrini; S Robertson; S F Berkovic; G D Jackson; I E Scheffer
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

8.  Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis.

Authors:  Balazs Hegedus; Tu-Hsueh Yeh; Da Yong Lee; Ryan J Emnett; Jia Li; David H Gutmann
Journal:  Hum Mol Genet       Date:  2008-07-09       Impact factor: 6.150

9.  Resting state functional MRI reveals abnormal network connectivity in neurofibromatosis 1.

Authors:  Steffie N Tomson; Matthew J Schreiner; Manjari Narayan; Tena Rosser; Nicole Enrique; Alcino J Silva; Genevera I Allen; Susan Y Bookheimer; Carrie E Bearden
Journal:  Hum Brain Mapp       Date:  2015-08-25       Impact factor: 5.038

10.  Brain and behaviour phenotyping of a mouse model of neurofibromatosis type-1: an MRI/DTI study on social cognition.

Authors:  L I Petrella; Y Cai; J V Sereno; S I Gonçalves; A J Silva; M Castelo-Branco
Journal:  Genes Brain Behav       Date:  2016-07-05       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.